BD (Becton, Dickinson and Company) announced it has obtained CE Mark approval for the Revello vascular covered stent for the ...

BD wins CE Mark for its Revello vascular covered stent for iliac artery disease, expanding its peripheral vascular portfolio ...

BD (NYSE: BDX) announced today that it received CE mark approval for its Revello vascular covered stent system.

Learn about peripheral artery disease and its effects on blood flow. We explain symptoms, risk factors, and treatments to ...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has obtained ...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has obtained ...

DelveInsight's Peripheral Vascular Devices Market Insights report provides the current and forecast market analysis, individual leading peripheral vascular devices companies' market shares, challenges ...

The global peripheral vascular devices market is experiencing steady growth, driven by rising incidences of cardiovascular diseases and an aging population. Advances in minimally invasive technologies ...

HOLX's Diagnostics unit faces COVID-19 test declines, but Panther Fusion expansion, new assays and AI-driven Genius system support long-term growth potential.

The Revello™ Vascular Covered Stent is designed to combine the flexibility of a nitinol self-expanding stent with the radial ...

Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (“Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through strategic partnerships with ...

Heart disease is one of the most serious challenges to global health. The incidence of heart-related diseases and life-threatening conditions is steadily increasing. You may have frequently heard of ...